Ralivia 100 mg

Ralivia 100 mg is an extended-release tramadol hydrochloride tablet used for managing moderate to severe pain. This prescription medication is designed for oral use and is manufactured by Bausch Health, Canada Inc.

Ralivia 100 mg is primarily used for pain management, particularly for moderate to severe pain that requires around-the-clock, long-term treatment. Tramadol hydrochloride, the active ingredient, is an opioid agonist that works by binding to opioid receptors in the brain to alter the perception of pain. This extended-release formulation is designed to provide sustained pain relief over an extended period.

Common effects of Ralivia 100 mg may include dizziness, nausea, constipation, and headache. Some users might experience drowsiness or vomiting. These effects can vary from person to person and may subside as the body adjusts to the medication.

Ralivia 100 mg should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored securely to prevent misuse. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Ralivia 100 mg may interact with other medications, including alcohol, antidepressants, and certain pain relievers. Combining tramadol hydrochloride with alcohol or other central nervous system depressants can increase the risk of severe side effects. It is advisable to consult a healthcare professional before starting or stopping any medication while taking Ralivia 100 mg.